Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 392.60
-0.05 (-0.01%)
Jun 10, 2025, 4:43 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €101.55 billion as of June 10, 2025. Its market cap has decreased by -4.72% in one year.
Market Cap
101.55B
Enterprise Value
93.05B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€392.60
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 101.55B, an increase of 137,343.92%. That is a compound annual growth rate of 23.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.05B |
| Merck KGaA | 50.09B |
| Bayer Aktiengesellschaft | 25.97B |
| Fresenius SE & Co. KGaA | 24.95B |
| Fresenius Medical Care AG | 14.76B |
| Sartorius Aktiengesellschaft | 12.87B |
| Carl Zeiss Meditec AG | 5.26B |
| Fielmann Group AG | 4.65B |